Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2005
09/28/2005EP1578983A2 Methods for regulating co-stimulatory molecule expression with reactive oxygen
09/28/2005EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof
09/28/2005EP1578955A2 Candida kefyr cytosine deaminase
09/28/2005EP1578954A2 5' cpg nucleic acids and methods of use
09/28/2005EP1578942A2 ANTISENSE MODULATION OF mitoNEET EXPRESSION
09/28/2005EP1578939A2 Translational control by small, non-translatable rnas
09/28/2005EP1578938A2 Promotion of peroxisomal catalase function in cells
09/28/2005EP1578933A2 Compositions and methods for si-rna inhibition of angiogenesis
09/28/2005EP1578931A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase
09/28/2005EP1578930A2 Cngh0004 polypeptides, antibodies, compositions, methods and uses
09/28/2005EP1578928A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity
09/28/2005EP1578927A2 Antisense modulation of nav1.3 expression
09/28/2005EP1578926A2 Novel prostate tumor-specific promoter
09/28/2005EP1578925A2 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
09/28/2005EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/28/2005EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
09/28/2005EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer
09/28/2005EP1578917A2 Multimeric proteins and methods of making and using same
09/28/2005EP1578916A2 Human ras interacting protein
09/28/2005EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/28/2005EP1578909A2 Excitatory glycine receptors and methods
09/28/2005EP1578908A2 Human schizophrenia gene
09/28/2005EP1578907A2 Secreted protein, ztnf9
09/28/2005EP1578906A2 Afap sequences, polypeptides, antibodies and methods
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578901A2 Linear dna fragments for gene expression
09/28/2005EP1578899A2 Secreted proteins
09/28/2005EP1578802A1 Dna/rna transduction technology and its clinical and basic applications
09/28/2005EP1578798A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours
09/28/2005EP1578797A1 The transmembrane protein amigo and uses thereof
09/28/2005EP1578794A1 A novel phosphoprotein
09/28/2005EP1578792A2 Novel centrosome-associated protein and applications thereof
09/28/2005EP1578789A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide
09/28/2005EP1578787A1 Novel chi-conotoxin peptides (-ii)
09/28/2005EP1578782A2 Combination therapy with co-stimulatory factors
09/28/2005EP1578780A2 Method to increase fibronectin
09/28/2005EP1578778A2 Ghrelin analogs
09/28/2005EP1578776A2 Products for regulating the degradation of collagen and methods for indentifying same
09/28/2005EP1578775A2 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange
09/28/2005EP1578773A2 Methods and products based on oligomerization of stress proteins
09/28/2005EP1578772A2 Cytokines and cytokine receptors with reduced immunogenicity
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578768A2 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use
09/28/2005EP1578767A2 Methods and materials for modulating trpm2
09/28/2005EP1578760A2 Compositions and methods for the diagnosis and treatment of tumor
09/28/2005EP1578480A2 Antagonists for human prolactin
09/28/2005EP1578439A2 Low dose methods for treating disorders in which tnf-alpha activity is detrimental
09/28/2005EP1578438A1 Synthetic peptide analogs for the treatment of cancer
09/28/2005EP1578437A1 Compositions and methods for the prevention and control of insulin-induced hypoglycemia
09/28/2005EP1578436A2 Saposing c and receptors as targets for treatment of benign and malignant disorders
09/28/2005EP1578435A2 Treatment of ophthalmic conditions with kpv and kpv dimers
09/28/2005EP1578434A2 Methods and compositions relating to isoleucine boroproline compounds
09/28/2005EP1578430A2 Treatment of diabetes
09/28/2005EP1578427A1 Use of gnrh agonists to support the luteal phase during infertility treatment
09/28/2005EP1578421A2 Pharmaceutical preparations for treatments of diseases and disorders of the breast
09/28/2005EP1578419A2 Immunostimulatory combinations
09/28/2005EP1578396A2 Methods and compositions concerning poxviruses and cancer
09/28/2005EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
09/28/2005EP1578381A2 Chemokine antagonists and uses thereof
09/28/2005EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer
09/28/2005EP1578373A2 Novel compositions and methods for the treatment of immune related diseases
09/28/2005EP1578369A2 Screening strategy for anticancer drugs
09/28/2005EP1578368A2 Compositions and methods for the treatment of rheumatoid arthritis
09/28/2005EP1578367A2 Compositions and methods for the treatment of immune related diseases
09/28/2005EP1578366A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
09/28/2005EP1578365A2 Molecular interactions in neurons
09/28/2005EP1578364A2 Compositions and methods for the treatmentof immune related diseases
09/28/2005EP1578362A2 Boroproline compound combination therapy
09/28/2005EP1578361A2 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
09/28/2005EP1578360A2 Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
09/28/2005EP1578358A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
09/28/2005EP1578355A2 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
09/28/2005EP1578352A2 Elastin prevents occlusion of body vessels by vascular smooth muscle cells
09/28/2005EP1578348A2 Formulation comprising bioactive agents and method of using same
09/28/2005EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/28/2005EP1578345A2 Peptides and antibodies to muc 1 proteins
09/28/2005EP1578325A2 Stable topical drug delivery compositions
09/28/2005EP1578317A2 Delivery of peroxide-generating enzymes to the vaginal tract
09/28/2005EP1578305A2 Canine rankl and methods for preparing and using the same
09/28/2005EP1578294A1 Methods and systems for enabling and stabilizing tooth movement
09/28/2005EP1578253A2 Prevention and treatment of synucleinopathic disease
09/28/2005EP1578211A2 Kolla 2-desiccated avian sternal cartilage powder
09/28/2005EP1578200A1 Cell-based vegf delivery
09/28/2005EP1578197A2 Composition and method for treating lupus nephritis
09/28/2005EP1578196A2 Mda-7 and free radicals in the treatment of cancer
09/28/2005EP1450838A4 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile
09/28/2005EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
09/28/2005EP1439846A4 Storage-stable human fibrinogen solutions
09/28/2005EP1402261A4 Colon cancer antigen panel
09/28/2005EP1356277A4 Method for altering cell fate
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1222913B1 Depilating method
09/28/2005EP1207885B1 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract
09/28/2005EP1141006B1 Topoisomerase ii inhibitor
09/28/2005EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS
09/28/2005EP1129194B1 Interleukin-1 homolog zil1a4
09/28/2005EP1117422B1 Use of op-1 for the preparation of a pharmaceutical composition for repairing a defect locus in a non articular cartilage tissue of a mammal
09/28/2005EP1037991B1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
1 ... 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 ... 3163